Cocrystal Pharma, Inc. (COCP): Free Cash Flow
-$8.20M
Year ended 2025-12-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$8.20M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$16.49M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$14.78M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$21.51M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$12.77M | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$10.07M | n/m | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | -$1.71M | n/m | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | -$8.32M | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$6.94M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$14.71M | n/m | 2018-03-21, From 2016-01-01 |
| 2015-12-31 | -$10.66M | n/m | 2018-03-21, From 2015-01-01 |
| 2014-12-31 | -$6.02M | n/m | 2017-03-31, From 2014-01-01 |
| 2013-12-31 | -$3.69M | n/c | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | -$1.74M | n/a | 2014-03-31, From 2012-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | -$8.20M | n/m |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | -$16.66M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$8.95M | n/m |
| Soligenix, Inc. (SNGX) | 2025-12-31 | -$10.27M | n/a |
| Longeveron Inc. (LGVN) | 2025-12-31 | -$18.89M | n/m |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $1.18M | -67.3% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | -$20.77M | n/m |
| Nanoviricides, Inc. (NNVC) | 2025-06-30 | -$8.54M | n/m |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | -$4.91M | n/m |
Compare COCP, FBLG, CANF, SNGX side by side · Screen every company in Pharmaceutical Preparations ↗